<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib68">
 <label>68</label>
 <element-citation publication-type="journal" id="sref68">
  <person-group person-group-type="author">
   <name>
    <surname>Turlington</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Chun</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Tomar</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Eggler</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Grum-Tokars</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Jacobs</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Daniels</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Dawson</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Saldanha</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chase</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Baez-Santos</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>Lindsley</surname>
    <given-names>C.W.</given-names>
   </name>
   <name>
    <surname>Hodder</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mesecar</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Stauffer</surname>
    <given-names>S.R.</given-names>
   </name>
  </person-group>
  <article-title>Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding</article-title>
  <source>Bioorg. Med. Chem. Lett</source>
  <volume>23</volume>
  <year>2013</year>
  <fpage>6172</fpage>
  <lpage>6177</lpage>
  <pub-id pub-id-type="pmid">24080461</pub-id>
 </element-citation>
</ref>
